FTC

Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Endpoints
Mon, 06/10/19 - 07:38 pm
Spark Therapeutics
Roche
FTC
UK
M&A
Judge, CVS witness clash on merger settlement, July hearing set
Biopharma Dive
Fri, 06/7/19 - 09:55 pm
M&A
CVS Health
Aetna
FTC
Pay-for-delay deals disappearing, FTC says
Biopharma Dive
Fri, 05/24/19 - 04:38 pm
FTC
generics
pay-for-delay
FTC Finds Dwindling Number of Anticompetitive Reverse Payment Deals
RAPS.org
Thu, 05/23/19 - 10:58 pm
FTC
Hatch Waxman Act
anticompetitive practices
Roche delays $4.3B Spark buyout — again — as FTC review drags on
Endpoints
Fri, 04/26/19 - 10:12 am
Roche
Spark Therapeutics
M&A
FTC
Impax in hot water for 'pay-for-delay' deal on Endo painkiller Opana ER, feds say
Fierce Pharma
Mon, 04/1/19 - 12:14 pm
FTC
pay-for-delay
Impax Laboratories
Endo
Amneal
Opana ER
Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal
TheStreet.com
Tue, 03/26/19 - 09:44 am
SEC
FTC
M&A
Bristol-Myers Squibb
Celgene
Trump to sign law allowing FTC to scrutinize biosimilar deals
Biopharma Dive
Wed, 10/10/18 - 12:36 pm
Donald Trump
biosimilars
antitrust
FTC
FTC Clears Takeda's Acquisition of Shire
CP Wire
Tue, 07/10/18 - 11:46 am
FTC
M&A
Takeda
Shire
Watch out, Allergan. Activist investor David Tepper won approval to push a shake-up
Fierce Pharma
Sat, 05/19/18 - 11:40 am
investors
Allergan
David Tepper
FTC
The FTC Appeals Shire ViroPharma Dismissal
FDA Law Blog
Thu, 04/19/18 - 09:08 am
FTC
Shire
ViroPharma
Hatch Waxman Act
Court Dismisses FTC’s Citizen Petition Complaint Against Shire
RAPS.org
Tue, 03/27/18 - 10:50 am
FTC
citizen petitions
Shire
ViroPharma
FDA chief to big pharma: ‘End the shenanigans’
Drug Delivery Business News
Thu, 11/9/17 - 05:56 pm
FDA
Scott Gottlieb
FTC
generics
competition
Pay-for-Delay Deals: FTC Notes Continued Decline Since SCOTUS Ruling
RAPS.org
Wed, 11/1/17 - 06:44 pm
FTC
pay-for-delay
Supreme Court
How Far Into the Drug Pipeline Should the FTC Reach?
TheStreet.com
Mon, 05/1/17 - 10:59 am
FTC
GSK
Novartis
BRAF inhibitor
MEK inhibitor
melanoma
Array Biopharma
M&A
Pharmaceutical Industry Cannibalization: The Launch of Authorized Generics After the Loss of Market Exclusivity
Xtalks
Mon, 03/13/17 - 10:11 am
generics
FDA
FTC
market exclusivity
Mylan hit with antitrust lawsuit over EpiPen device
Mass Device
Wed, 02/1/17 - 09:36 am
Mylan Labs
antitrust
EpiPens
drug pricing
FTC
FTC, Endo propose agreement to resolve pay-for-delay dispute
Bizjournals.com
Tue, 01/24/17 - 09:54 am
FTC
Endo International
pay-for-delay
Opana ER
lidoderm
FTC is ‘aware’ of concerns over possible Mylan antitrust violations
Stat/Pharmalot
Mon, 11/21/16 - 11:37 am
FTC
Mylan Labs
antitrust
FTC Clears Teva Pharmaceutical Industries-Allergan plc Generics Deal; What's Next?
Bidness, ETC
Sat, 07/30/16 - 09:45 pm
FTC
Teva Pharmaceuticals
Allergan
generics

Pages